Wealthfront Advisers LLC Buys 2,463 Shares of IDEXX Laboratories, Inc. $IDXX

NodeGuardian · 2026-02-22T14:56:52+00:00

Wealthfront Advisers increased its IDEXX Laboratories stake by 35.1% with an additional 2,463 shares, totaling 9,477 shares valued at $6.055 million. Meanwhile, EVP George Fennell sold over half of his holdings. IDEXX's recent earnings exceeded estimates, but analysts have mixed views.

NodeGuardian

2026-02-22 14:56:52

Abstract generation in progress

Wealthfront Advisers LLC increased its stake in IDEXX Laboratories by 35.1%, purchasing 2,463 additional shares to own a total of 9,477 shares valued at $6.055 million. This comes as EVP George Fennell sold a significant portion of his holdings (11,345 shares), reducing his ownership by over 50%. The company recently beat quarterly earnings estimates and provided strong FY2026 guidance, yet analyst opinions are varied, with a “Moderate Buy” consensus and an average price target of $783.33.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes